The company relies on both internal information technology (IT) systems and networks, and those of third parties and their vendors, to process and store sensitive data, including confidential research, business plans, financial information, intellectual property, and personal data. The extensive information security and cybersecurity threats pose a risk to the security and availability of these IT systems and networks, and the confidentiality, integrity, and availability of the company's sensitive data. The company continually assesses these threats and makes investments to increase internal protection, detection, and response capabilities, as well as ensure the company's third-party providers have required capabilities and controls to address this risk. The company has not experienced any material impact to its business or operations resulting from information or cybersecurity attacks; however, due to the frequently changing attack techniques, there is the potential for the company to be adversely impacted, resulting in reputational, competitive, operational, or other business harm as well as financial costs and regulatory action. The company manages within a strategic framework with a focus on long-term growth drivers, including creating value through innovation and excellence in execution. The company invests significantly in research and development, reflecting its commitment to delivering new and differentiated products and services to meet evolving healthcare needs. The management's decentralized approach allows leveraging extensive resources of the enterprise to innovate and execute strategic plans effectively. The company faces substantial competition in all operating segments and geographic markets, competing on the basis of technological innovations, product performance, and intellectual property rights. The competitive environment requires substantial investments in continuing research and development, and the company is committed to developing accessible, high-quality, innovative products and services. The company’s businesses operate in highly competitive product markets, and competitive pressures could adversely affect earnings. The company also faces various risks associated with conducting business internationally, including regulatory scrutiny, compliance costs, and the impact of economic conditions on operations. The company’s ability to innovate and develop new products is crucial for long-term success, as significant challenges or delays in innovation could negatively impact growth. The company’s organizational capabilities are essential in addressing the evolving healthcare needs of patients, providers, and consumers. The company’s management practices are focused on sustaining market leadership positions and enabling growth, which provides enduring value to shareholders. The company’s strategic resource allocation and operational flexibility are critical in responding to market dynamics and competitive actions. The company continually assesses the likely outcomes of its tax audits and maintains a focus on compliance with various regulations affecting its operations. The company’s extensive operations require timely delivery of high-quality components and materials, and interruptions in manufacturing could adversely affect business performance. The company’s IT capabilities are integral to supporting business needs and enhancing operational efficiency, which is essential for maintaining competitive advantage in the healthcare industry.